Michael H. Rivner

BCMA-directed mRNA CAR-T cell therapy for myasthenia gravis: exploratory biomarker analysis of a placebo-controlled phase 2b trial

Renee Fedak, Rachel N. Ruggerie, Yufei Shan, Elizabeth J. Curvino et autres

us, tr, ca (code pays fourni par la source)

BCMA-directed mRNA CAR T cell therapy for myasthenia gravis: a randomized, double-blind, placebo-controlled phase 2b trial

Tuan Vu, Hacer Durmuş, Michael H. Rivner, Sheetal Shroff et autres

us, tr, ca (code pays fourni par la source)

BCMA-directed mRNA CAR T cell therapy for myasthenia gravis: a randomized, double-blind, placebo-controlled phase 2b trial

Tuan Vu, Hacer Durmus, Michael H. Rivner, Sheetal Shroff et autres

Multicenter Expanded Access Protocol for Research Through Access to Trehalose in People With Amyotrophic Lateral Sclerosis

Brooke Krivickas, Erica Scirocco, Elisa Giacomelli, Saloni Sharma et autres

us (code pays fourni par la source)

ALSUntangled #80: ISRIB (Integrated stress response InhiBitor)

Javier Mascías Cadavid, Anna Mena Bravo, Paul E. Barkhaus, Benjamin Barnes et autres

es, us, se, gb, ca, ru (code pays fourni par la source)

Efficacy and Safety of Autologous BCMA-directed mRNA CAR T-Cell Therapy in Generalized Myasthenia Gravis: Results from a Phase 2b Randomized Placebo-controlled Trial

Tuan Vu, Hacer Durmuş Tekçe, Michael H. Rivner, Sheetal Shroff et autres

Efficacy and Safety of Autologous BCMA-directed mRNA CAR T-Cell Therapy in Generalized Myasthenia Gravis: Results from a Phase 2b Randomized Placebo-controlled Trial (S34.002)

Tuan Vu, Hacer Durmuş Tekçe, Michael H. Rivner, Sheetal Shroff et autres

us, tr, ca (code pays fourni par la source)

Safety and efficacy of chronic weekly rozanolixizumab in generalized myasthenia gravis: the randomized open-label extension MG0004 study

Vera Bril, Artur Drużdż, Julian Großkreutz, Ali A. Habib et autres

ca, de, us, it, fr, jp, dk (code pays fourni par la source)

Efficacy and safety of maintenance intravenous immunoglobulin in generalized myasthenia gravis patients with acetylcholine receptor antibodies: A multicenter, double‐blind, placebo‐controlled trial

Vera Bril, Tomasz Berkowicz, Andrzej Szczudlik, Michael Nicolle et autres

ca, pl, cz, lt, us, hu, de, ee, gr, es (code pays fourni par la source)

Safety and tolerability of tegoprubart in patients with amyotrophic lateral sclerosis: A Phase 2A clinical trial

Steven Perrin, Shafeeq Ladha, Nicholas J. Maragakis, Michael H. Rivner et autres

us, ca (code pays fourni par la source)

Efficacy, safety and tolerability of rozanolixizumab in patients with chronic inflammatory demyelinating polyradiculoneuropathy: a randomised, subject-blind, investigator-blind, placebo-controlled, phase 2a trial and open-label extension study

Luís Querol, de Sèze, Tina Dysgaard, Todd Levine et autres

es, fr, dk, us, au, de, cz, be, gb, nl (code pays fourni par la source)

Safety and efficacy of zilucoplan in patients with generalised myasthenia gravis (RAISE): a randomised, double-blind, placebo-controlled, phase 3 study

James F. Howard, Saskia Bresch, Angela Genge, Channa Hewamadduma et autres

us, fr, ca, gb, es, no, it, jp, pl, de, be (code pays fourni par la source)